Signal active
Organization
Contact Information
Overview
PerceptiMed’s groundbreaking VeriFill™ technology reduces the margin of human error in prescription pill dispensing within retail pharmacies, long-term care facilities and hospitals. Its IdentRx™suite of medication verification and dispensing products are fast, accurate and cost-effective -- providing 100% verification of drug, dosage and manufacturer for every pill, every time.
About
Biotechnology, Health Care, Medical, Medical Device
2011
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
PerceptiMed headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $706.8M in funding across 64 round(s). With a team of 11-50 employees, PerceptiMed is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - PerceptiMed, raised $3.1M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
4
1
0
$11.0M
Details
1
PerceptiMed has raised a total of $11.0M in funding over 1 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2015 | Early Stage Venture | 5.4M |
Investors
PerceptiMed is funded by 9 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Lisa Rhoads | - | FUNDING ROUND - Lisa Rhoads | 3.1M |
John H. Friedman | - | FUNDING ROUND - John H. Friedman | 3.1M |
PerceptiMed | - | FUNDING ROUND - PerceptiMed | 3.1M |
Easton Capital | - | FUNDING ROUND - Easton Capital | 3.1M |
Recent Activity
There is no recent news or activity for this profile.